Pressemeldungen
neurocare group has received approval to market its TMS devices in Saudi Arabia, marking a significant advancement in mental health...
NRx Pharmaceuticals and neurocare Group AG launch a nationwide program integrating TMS, medications, and psychotherapy to treat Depression,...
FDA clears neurocare group's Apollo TMS Therapy for adolescent depression, offering a safe, non-invasive alternative to traditional...
Leadership continuity positions neurocare for its next decade of global expansion, innovation, and patient impact.


